Quince Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QNCX and other ETFs, options, and stocks.

About QNCX

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells.

CEO

Dirk Thye

CEODirk Thye

Employees

Employees36

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2012

Founded2012

Employees

Employees36

QNCX Key Statistics

Market cap

140.32M

Market cap140.32M

Price-Earnings ratio

-2.05

Price-Earnings ratio-2.05

Dividend yield

—

Dividend yield—

Average volume

567.80K

Average volume567.80K

High today

$2.70

High today$2.70

Low today

$2.15

Low today$2.15

Open price

$2.15

Open price$2.15

Volume

1.55M

Volume1.55M

52 Week high

$2.70

52 Week high$2.70

52 Week low

$0.7203

52 Week low$0.7203

Stock Snapshot

As of today, Quince Therapeutics(QNCX) shares are valued at $2.45. The company's market cap stands at 140.32M, with a P/E ratio of -2.05.

As of 2025-11-25, Quince Therapeutics(QNCX) stock has fluctuated between $2.15 and $2.70. The current price stands at $2.45, placing the stock +14.0% above today's low and -9.3% off the high.

The Quince Therapeutics(QNCX)'s current trading volume is 1.55M, compared to an average daily volume of 567.8K.

During the past year, Quince Therapeutics(QNCX) stock moved between $0.72 at its lowest and $2.70 at its peak.

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own QNCX. This list is generated using Robinhood data, and it’s not a recommendation.